药物在预防、治疗水产品疾病的同时也带来了药物 残留(简称药残)的问题。水产品药物残留不仅对人体 健康造成潜在危害,而且还影响着水产品进出口贸易, 成为出口贸易的瓶颈。因此加强水产品药物残留监管, 提高质量安全水平已是刻不容缓。 Drugs in the prevention and treatment of aquatic diseases also brought the issue of drug residues (referred to as drug residues). Residues of aquatic products not only cause potential harm to human health, but also affect the import and export of aquatic products and become the bottleneck of export trade. Therefore, it is imperative to step up the regulation of drug residues in aquatic products and improve the quality and safety of aquatic products.